Literature DB >> 21153890

Metabolic syndrome: a new multidisciplinary service line.

Eldo E Frezza1, Mitchell Wachtel.   

Abstract

That obesity in the USA has reached epidemic proportions is undeniable: one in three American adults is obese. High levels of obesity yield adverse microeconomic and macroeconomic effects, but assessing the viability of bariatric surgery in this respect requires careful consideration of its efficacy, its economic costs, and the benefits of the surgery. Metabolic syndrome is a microcosm of multiple disease states; the diseases that fall under the umbrella of the metabolic syndrome are, like obesity, becoming more prevalent. Epidemic obesity in part reflects inadequate utilization of bariatric surgery and inadequate coordination of efforts by the healthcare system. An integrated delivery network (IDN) is the best current model to achieve healthcare goals for patient subsets that are deemed important. Our overweight population, both with and without the metabolic syndrome, constitutes such a group because of the fraction of the general population they compose, the inherent costs to the healthcare system that their comorbid conditions generate, and the lost productivity to our economy that the treatment of these conditions entail. In this paper, we show a metabolic syndrome service line that will benefit both the individual hospital and the healthcare system. Pathways accepted for bariatric practices can be used, with modification, for the creation of a metabolic syndrome IDN. Implementation of such a system would benefit patients, caregivers, and society.

Entities:  

Mesh:

Year:  2011        PMID: 21153890     DOI: 10.1007/s11695-010-0330-9

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  24 in total

1.  Building integrated systems--the holographic organization.

Authors:  S M Shortell; D A Anderson; R R Gillies; J B Mitchell; K L Morgan
Journal:  Healthc Forum J       Date:  1993 Mar-Apr

2.  A model for product line management in health care.

Authors:  M P Charns; L S Tewksbury
Journal:  Aust Health Rev       Date:  1991       Impact factor: 1.990

3.  Relation of body mass index in young adulthood and middle age to Medicare expenditures in older age.

Authors:  Martha L Daviglus; Kiang Liu; Lijing L Yan; Amber Pirzada; Larry Manheim; Willard Manning; Daniel B Garside; Renwei Wang; Alan R Dyer; Philip Greenland; Jeremiah Stamler
Journal:  JAMA       Date:  2004-12-08       Impact factor: 56.272

4.  The effect of obesity and cardiometabolic risk factors on expenditures and productivity in the United States.

Authors:  Patrick W Sullivan; Vahram Ghushchyan; Rami H Ben-Joseph
Journal:  Obesity (Silver Spring)       Date:  2008-09       Impact factor: 5.002

Review 5.  A successful model of setting up a bariatric practice.

Authors:  Eldo E Frezza; Mitchell S Wachtel
Journal:  Obes Surg       Date:  2008-03-18       Impact factor: 4.129

6.  Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients.

Authors:  Nicolas V Christou; John S Sampalis; Moishe Liberman; Didier Look; Stephane Auger; Alexander P H McLean; Lloyd D MacLean
Journal:  Ann Surg       Date:  2004-09       Impact factor: 12.969

Review 7.  Health economics of weight management: evidence and cost.

Authors:  Antigone Kouris-Blazos; Mark L Wahlqvist
Journal:  Asia Pac J Clin Nutr       Date:  2007       Impact factor: 1.662

Review 8.  Economic costs of diabetes in the U.S. In 2007.

Authors: 
Journal:  Diabetes Care       Date:  2008-03       Impact factor: 19.112

9.  Cost effectiveness analysis of a hypertension management program in patients with type 2 diabetes.

Authors:  David Ly; Alex Z Fu; Fu Z Alex; Christopher Hebert; Hebert Christopher
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-03       Impact factor: 3.738

Review 10.  Blood pressure reduction, persistence and costs in the evaluation of antihypertensive drug treatment--a review.

Authors:  Peter Bramlage; Joerg Hasford
Journal:  Cardiovasc Diabetol       Date:  2009-03-27       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.